Searchable abstracts of presentations at key conferences in endocrinology

ea0009p91 | Endocrine tumours and neoplasia | BES2005

Superoxide dismutase expression in human uterine cervix carcinoma cells (HeLaS3) treated with cytostatics or nucleoside drug

Adzic M , Niciforovic A , Isenovic E , Radojcic M

Objective: Because the altered expression of superoxide dismutases, CuZn (SOD1) and Mn (SOD2) have been shown to constitute the basis of either resistance or susceptibility to the cytotoxic effect of various cytostatics and nucleoside drugs, we tested whether in human uterin cervix carcinoma cells (HeLaS3) the cytotoxic effect of cytostatics adriamycin (Adr), and cis-platinum (CP) or nucleoside drug, tiazofurin (TF) were involved in the activity of SOD1 and SOD2. Methods: Cyto...